As of 9:17:53 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
53,835.0290
45,035.0290
31,801.6670
27,250.4230
17,564.3990
Operating Income
-53,835.0290
-45,035.0290
-31,801.6670
-27,250.4230
-17,564.3990
Net Non Operating Interest Income Expense
1,148.3560
848.3560
-33.0760
-3.8410
2.5560
Pretax Income
-52,656.9640
-44,156.9640
-31,755.6980
-27,174.8620
-17,541.1710
Net Income Common Stockholders
-52,656.9640
-44,156.9640
-31,755.6980
-27,174.8620
-17,541.1710
Diluted NI Available to Com Stockholders
-52,656.9640
-44,156.9640
-31,755.6980
-27,174.8620
-17,541.1710
Basic EPS
-0.04
-0.06
-0.19
-0.20
-0.30
Diluted EPS
-0.04
-0.06
-0.19
-0.20
-0.30
Basic Average Shares
1,003,073.0500
720,237.0560
163,479.7330
131,611.0140
58,670.0400
Diluted Average Shares
1,101,791.9000
917,356.8340
164,993.1680
142,265.6430
58,670.0400
Total Operating Income as Reported
-45,005.3200
-45,005.3200
-31,722.6220
-27,171.0210
-17,543.7270
Total Expenses
53,835.0290
45,035.0290
31,801.6670
27,250.4230
17,564.3990
Net Income from Continuing & Discontinued Operation
-52,656.9640
-44,156.9640
-31,755.6980
-27,174.8620
-17,541.1710
Normalized Income
-52,659.3490
-44,159.3490
-31,755.6980
-27,204.3620
-17,541.1710
Interest Income
--
914.4970
--
0.0290
8.4700
Interest Expense
--
66.1410
33.0760
3.8700
5.9140
Net Interest Income
1,148.3560
848.3560
-33.0760
-3.8410
2.5560
EBIT
-52,890.8230
-44,090.8230
-31,722.6220
-27,170.9920
-17,535.2570
EBITDA
-52,883.2710
-44,083.2710
-31,715.0690
-27,163.4390
-17,533.4410
Reconciled Depreciation
7.5520
7.5520
7.5530
7.5530
1.8160
Net Income from Continuing Operation Net Minority Interest
-52,656.9640
-44,156.9640
-31,755.6980
-27,174.8620
-17,541.1710
Total Unusual Items Excluding Goodwill
2.3850
2.3850
--
29.5000
--
Total Unusual Items
2.3850
2.3850
--
29.5000
--
Normalized EBITDA
-52,885.6560
-44,085.6560
-31,715.0690
-27,192.9390
-17,533.4410
12/31/2020 - 8/25/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
29A.SG Amphastar Pharmaceuticals Inc
34.66
-0.14%
068760.KQ Celltrion Pharm, Inc.
56,900.00
-1.22%
27N0.DU Cannovum Cannabis AG
0.5000
+0.40%
ERMA.ST Enorama Pharma AB (publ)
3.6700
+5.16%
0ET.MU Esperion Therapeutics Inc
2.1410
0.00%
CRFTF BC Craft Supply Co. Ltd.
0.0001
0.00%
RIG2.BE Chemical Works of Gedeon Richter PLC
25.16
-0.55%
11L.MU Canopy Growth Corp. R
2.5700
-0.39%
R9U2.F Green Thumb Industries Inc.
7.42
+2.77%
CEL.L Celadon Pharmaceuticals Plc
14.00
-12.50%